Nuclear factor of activated T-cells, NFATC1, governs FLT3ITD-driven hematopoietic stem cell transformation and a poor prognosis in AML

被引：0
|
作者：
Maria Solovey
Ying Wang
Christian Michel
Klaus H. Metzeler
Tobias Herold
Joachim R. Göthert
Volker Ellenrieder
Elisabeth Hessmann
Stefan Gattenlöhner
Andreas Neubauer
Dinko Pavlinic
Vladimir Benes
Oliver Rupp
Andreas Burchert
机构：
[1] Philipps University Marburg,Department of Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Campus Marburg
[2] LMU Munich,Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital
[3] University Hospital Essen,Department of Hematology
[4] University Hospital Goettingen,Department of Gastroenterology
[5] Justus-Liebig-University,Institute of Pathology
[6] EMBL Heidelberg ,Genomics Core Facility
[7] University Giessen,Department of Bioinformatics and Systems Biology
来源：
Journal of Hematology & Oncology | / 12卷
关键词：
FLT3; Acute myeloid leukemia; Hematopoietic stem cells; NFATC1; Drug resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Nuclear factor of activated T-cells, NFATC1, governs FLT3ITD-driven hematopoietic stem cell transformation and a poor prognosis in AML
    Solovey, Maria
    Wang, Ying
    Michel, Christian
    Metzeler, Klaus H.
    Herold, Tobias
    Goethert, Joachim R.
    Ellenrieder, Volker
    Hessmann, Elisabeth
    Gattenloehner, Stefan
    Neubauer, Andreas
    Pavlinic, Dinko
    Benes, Vladimir
    Rupp, Oliver
    Burchert, Andreas
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [2] Notch Suppresses Nuclear Factor of Activated T Cells (Nfat) Transactivation and Nfatc1 Expression in Chondrocytes
    Zanotti, Stefano
    Canalis, Ernesto
    ENDOCRINOLOGY, 2013, 154 (02) : 762 - 772
  • [3] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1
    Kim, Hyeoung-Joon
    Kim, TaeHyung
    Kook, Hoon
    Song, Ga-Young
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Kim, Mihee
    Yang, Deok-Hwan
    Lee, Je-Jung
    Choi, Seung Hyun
    Kim, Mi Yeon
    Jung, Chul Won
    Jang, Jun-Ho
    Kim, Hee Je
    Moon, Joon Ho
    Sohn, Sang Kyun
    Won, Jong-Ho
    Park, Seong-Kyu
    Kim, Sung-Hyun
    Zhang, Zhaolei
    Ahn, Jae-Sook
    Kim, Dennis Dong Hwan
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 172 - 173
  • [4] Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1)
    Vaeth, Martin
    Gogishvili, Tea
    Bopp, Tobias
    Klein, Matthias
    Berberich-Siebelt, Friederike
    Gattenloehner, Stefan
    Avots, Andris
    Sparwasser, Tim
    Grebe, Nadine
    Schmitt, Edgar
    Huenig, Thomas
    Serfling, Edgar
    Bodor, Josef
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (06) : 2480 - 2485
  • [5] Distinct Activation Properties of the Nuclear Factor of Activated T-cells (NFAT) Isoforms NFATc3 and NFATc4 in Neurons
    Ulrich, Jason D.
    Kim, Man-Su
    Houlihan, Patrick R.
    Shutov, Leonid P.
    Mohapatra, Durga P.
    Strack, Stefan
    Usachev, Yuriy M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (45)
  • [6] PPP3CB contributes to poor prognosis through activating nuclear factor of activated T-cells signaling in neuroblastoma
    Shakhova, Irina
    Li, Yuanyuan
    Yu, Fan
    Kaneko, Yoshiki
    Nakamura, Yohko
    Ohira, Miki
    Izumi, Hideki
    Mae, Takao
    Varfolomeeva, Svetlana R.
    Rumyantsev, Alexander G.
    Nakagawara, Akira
    MOLECULAR CARCINOGENESIS, 2019, 58 (03) : 426 - 435
  • [7] ASSOCIATION OF NUCLEAR FACTOR OF ACTIVATED T CELLS CYTOPLASMIC 1 (NFATC1) EXPRESSION WITH CARDIOVASCULAR RISK IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Genre, F.
    Pulito-Cueto, V.
    Corrales, A.
    Portilla, V.
    Lera-Gomez, L.
    Atienza-Mateo, B.
    Gualillo, O.
    Blanco, R.
    Ferraz-Amaro, I.
    Castaneda, S.
    Lopez-Mejias, R.
    Gonzalez-Gay, M. A.
    Remuzgo-Martinez, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1167 - 1167
  • [8] Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor, signaling
    Akimzhanov, Askar
    Krenacs, Laszlo
    Schlegel, Timm
    Klein-Hessling, Stefan
    Bagdi, Enikoe
    Stelkovics, Eva
    Kondo, Eisaku
    Chuvpilo, Sergei
    Wilke, Philipp
    Avots, Andris
    Gattenloehner, Stefan
    Mueller-Hermelink, Hans-Konrad
    Palmetshofer, Alois
    Serfling, Edgar
    AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (01): : 215 - 224
  • [9] Nuclear factor of activated T cells 1 (NFATc1) in CD11c+dendritic cells drives eosinophilic inflammation in asthmatic patients
    Yang, Z.
    Krammer, S.
    Grund, J.
    Mitlander, H.
    Zirlik, S.
    Finotto, S.
    ALLERGY, 2023, 78
  • [10] Positive Minimal Residual Disease of FLT3-ITD before Hematopoietic Stem Cell Transplantation Resulted in a Poor Prognosis of an Acute Myeloid Leukemia
    Iwasaki, Yuka
    Nishiuchi, Rituo
    Aoe, Michinori
    Takahashi, Takahide
    Watanabe, Hirokazu
    Tokorotani, Chiho
    Kikkawa, Kiyoshi
    Shimada, Akira
    ACTA MEDICA OKAYAMA, 2017, 71 (01) : 79 - 83
12345